SEC Form 4 insider trading filings tracked in real time from EDGAR

HENDERSON MICHAEL THOMAS — Chief Executive Officer

Insider trading activity for HENDERSON MICHAEL THOMAS sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Executive Officer
  • Company: Apogee Therapeutics, Inc.
  • Total insider trades: 20
  • Total buy volume: $0
  • Total sell volume: $23.5M
  • Last trade: Jun 24, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 22, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 80,000 $10.6M
Jun 22, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. SELL 20,000 $2.0M
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 614 $53K
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 2,305 $199K
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 1,577 $134K
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 1,080 $91K
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 7,654 $634K
Jun 10, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 6,770 $557K
May 27, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. OTHER 8,026 N/A
May 13, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 1,341 $111K
May 13, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 18,659 $1.5M
May 8, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. SELL 19,269 $1.5M
May 8, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. SELL 24,814 $1.9M
May 8, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. SELL 33,513 $2.5M
May 8, 2026 HENDERSON MICHAEL THOMAS SYRE Spyre Therapeutics, Inc. SELL 2,404 $174K
Apr 16, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. OTHER 3,000 N/A
Apr 16, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. OTHER 3,000 $69K
Apr 8, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 200 $17K
Apr 8, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 2,000 $167K
Apr 8, 2026 HENDERSON MICHAEL THOMAS APGE Apogee Therapeutics, Inc. SELL 17,800 $1.5M

← All executives · Full trades feed